Skip to main content
. 2020 Oct 7;124(2):484–493. doi: 10.1038/s41416-020-01112-z

Fig. 1. KDM2A expression in tumour stroma is associated with poor survival of breast cancer patients.

Fig. 1

a Expression of KDM2A in breast tumour stroma was detected by immunohistochemical staining and the tumours with low (left) and high (right) expression were shown. b Disease-specific survival of 184 breast cancer patients with low or high KDM2A was compared. P = 0.0012. c Metastasis-free survival of 184 breast cancer patients with low or high KDM2A was compared. P < 0.0001.